Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3149589 | 0.84 | ALDH1A1 (0.38) | TDP1ALDH1A1CYP1A2CYP3A4HSD17B10 | |
| SCHEMBL2152944 | 0.84 | TDP1 (0.44) | TDP1CYP2A6ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL79020 | 0.84 | ALDH1A1 (0.35) | TDP1CYP2A6ALDH1A1TSHRHSD17B10 | |
| SCHEMBL2102041 | 0.83 | CYP2A6 (0.38) | TDP1CYP2A6ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL7139286 | 0.81 | ALDH1A1 (0.41) | TDP1CYP2A6ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL28957329 | 0.81 | CYP1A2 (0.41) | CYP2A6ALDH1A1HPGDSMN1; SMN2TSHR | |
| SCHEMBL8359885 | 0.81 | MEN1 (0.42) | TDP1ALDH1A1HPGDSMN1; SMN2TSHR | |
| SCHEMBL8325832 | 0.81 | CYP1A2 (0.39) | CYP2A6HPGDSMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL9418157 | 0.81 | ESR1 (0.47) | ALDH1A1HPGDCYP1A2HSD17B10RAB9A | |
| SCHEMBL4156055 | 0.80 | CYP2A6 (0.39) | TDP1CYP2A6ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9233138-B2 | Compositions for promoting HIV-1 virolysis and methods using same | DREXEL UNIVERSITY (US) | 2016-01-12 | — | — | US | claimed |
| EP-1660404-A2 | HYDROGEN STORAGE REVERSIBLE HYDROGENATED OF PI-CONJUGATED SUBSTRATES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-05-31 | — | — | EP | claimed |
| EP-1499588-A1 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-26 | — | — | EP | claimed |
| US-20050013767-A1 | dispenser for dispensing first liquid and retrieving second liquid comprising first conduit for dispensing first liquid and second conduit for retrieving second liquid in direction countercurrent to first liquid; for hydrogen storage liquids comprising partially hydrogenated pi-conjugated substrates | AIR PRODUCTS AND CHEMICALS, INC. | 2005-01-20 | — | — | US | claimed |
| WO-2005000457-A2 | HYDROGEN STORAGE REVERSIBLE HYDROGENATED OF PI-CONJUGATED SUBSTRATES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-01-06 | — | — | WO | claimed |
| WO-2003093234-A1 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2003-11-13 | — | — | WO | claimed |
| EP-2960204-A1 | HYDROGEN STORAGE BY REVERSIBLE HYDROGENATION OF PI-CONJUGATED SUBSTRATES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-12-30 | — | — | EP | disclosed |
| EP-2590935-A1 | PROCESS FOR MAKING NITRILES | Invista Technologies S.a r.l. (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-1849778-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE PROCESS, AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8394974-B2 | Process for producing optically active chromene oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8217184-B2 | Process for producing optically active cis-silyl olefin oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| EP-1283441-A1 | Chemically sensitized aqueous-based photothermographic emulsions and materials and methods of using same | EASTMAN KODAK COMPANY (US) | 2003-02-12 | — | — | EP | disclosed |
| US-6441174-B1 | REACTING PERYLENE-3,4,9,10-TETRACARBOXIMIDE OR DERIVATIVES WITH FORMALDEHYDE TO FORM BIS(HYDROXYMETHYL)PERYLENE-3,4,9,10-TETRACARBOXIMIDE, WHICH FURTHER REACTS WITH A PRECURSOR OF ORGANIC REDICALS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-08-27 | — | — | US | disclosed |
| US-6340552-B1 | AS PHOTORESISTS IN MANUFACTURING SEMICONDUCTORS | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-01-22 | — | — | US | disclosed |
| US-5372914-A | Pattern forming method | KABUSHIKI KAISHA TOSHIBA (JP) | 1994-12-13 | — | — | US | disclosed |
| US-5348838-A | Photoresist | KABUSHIKI KAISHA TOSHIBA (JP) | 1994-09-20 | — | — | US | disclosed |
| US-5332648-A | Alklali soluble phenolic polymer, cyclic ester or sulfonate which converts to the acid, an onium salt which generates an an acid on exposure to radiation | KABUSHIKI KAISHA TOSHIBA (JP) | 1994-07-26 | — | — | US | disclosed |
| US-5130058-A | Reversable coloring compounds with heat stability for lasers, photography, optical filters, decorations and displays | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1992-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | CYP4F11, CYP51A1, COASY | TDP1 4140/4885CYP2A6 212/4885ALDH1A1 2091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.